Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma × Leucovorin × Clear all

Phase

Phase 2 3 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 110 Colonic Neoplasms 62 Rectal Neoplasms 53 Neoplasm Metastasis 21 Pancreatic Neoplasms 18 Stomach Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Neoplasms 10 Leukemia 9 Carcinoma, Hepatocellular 9 Lymphoma 8 Adenocarcinoma Of Esophagus 8 Burkitt Lymphoma 7 Cholangiocarcinoma 6 Esophageal Neoplasms 5 Adenocarcinoma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Intestinal Neoplasms 4 Gastrointestinal Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Digestive System Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Gallbladder Neoplasms 3 Biliary Tract Neoplasms 3 Rectal Diseases 2 Neurotoxicity Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Biphenotypic, Acute 2

Interventions

Carboplatin 15 Cisplatin 12 Paclitaxel 11 Pemetrexed 10 pembrolizumab 9 Gemcitabine 7 Docetaxel 6 durvalumab 4 Sorafenib 4 130-nm albumin-bound paclitaxel 4 osimertinib 3 cabozantinib 3 Taxes 3 Radiotherapy 3 Mitomycin 3 Magnetic Resonance Spectroscopy 3 Cetuximab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 trifluridine tipiracil drug combination 2 regorafenib 2 padeliporfin 2 olaparib 2 atezolizumab 2 Sunitinib 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Nivolumab 2 Irinotecan 2 Everolimus 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02539537 2024-01-09

NEOPAN

UNICANCER

Phase 3 Completed

Gastrointestinal

Carcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡